查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829747

2025年多重PCR检测全球市场报告

Multiplex PCR Assays Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，多重PCR检测市场快速扩张，市场规模从2024年的15.1亿美元成长至2025年的17亿美元，复合年增长率为12.8%。预测期内的成长归因于感染疾病病率的上升、政府资金和支持的增加、临床诊断应用的增加、基因检测和个性化医疗的增加、学术研究实验室应用的增加、生物资讯学和数据分析工具的进步以及医疗保健支出的增加。

预计未来几年，多重PCR检测市场将快速成长，到2029年将达到28亿美元，复合年增长率为13.3%。预测期内的成长动力包括：应用领域不断扩大、照护现场诊断需求不断增长、个人化医疗发展、研发支出不断增加、健康意识和预防性医疗保健日益增强、精准医疗日益受到重视，以及对快速可靠诊断检测的需求不断增长。预测期内的主要趋势包括：次世代定序(NGS) 整合、伴随诊断、数位PCR技术、自动化和高通量系统、照护现场和可携式设备、客製化和多重侦测能力、人工智慧和机器学习、增强型资料管理以及云端解决方案。

多重PCR检测是一种先进的聚合酵素链锁反应)技术，旨在透过单次反应同时扩增和检测多个DNA或RNA标靶。此方法可同时分析多种遗传标记和病原体，提供全面、经济高效的检测结果，并显着提高效率。

多重PCR检测主要分为平面PCR和以微珠为基础。平面PCR检测在平面或平台（例如微孔盘或玻片）上进行，并安装探针阵列以检测单一样本中的多个靶标，从而实现高效、高通量分析。产品和服务包括应用于疾病诊断、研发等领域的耗材、仪器、软体和服务。这些技术的最终用户包括生物製药公司、临床研究实验室、学术研究机构和诊断中心。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是一家商业研究公司发布的一系列新报告的一部分，该系列报告提供多重 PCR 检测市场统计数据，例如全球市场规模、区域份额、竞争对手的多重 PCR 检测市场份额、详细的多重 PCR 检测细分市场、市场趋势和商机，以及您在多重 PCR 检测行业取得成功所需的数据。本多重 PCR 检测市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为13.3%，较我们先前对该市场的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响将透过对芬兰专用聚合酵素征收关税直接影响美国，这可能会增加综合诊断试剂盒的成本，并限制多病原体检测试剂的供应。此外，互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响也将更广泛地反映出来。

诊断检测需求的不断增长预计将推动多重PCR检测市场的扩张。诊断检测包括用于确定患者是否有疾病或病症的程序和测试。癌症和糖尿病等慢性疾病的日益流行，需要早期准确的诊断才能有效管理。此外，对预防性医疗保健的重视也推动了定期检测，以便及早发现潜在的健康问题。多重PCR检测能够从单一样本同时检测和分析多种病原体和遗传标记，从而提高诊断检测的效率和准确性。例如，英国国家医疗服务体系（NHS）在2024年7月报告称，2023年的诊断活动超过了疫情前的水平，2024年5月进行的检测同比增长了21%。此外，2024年5月进行了240万次诊断测试。这种日益增长的诊断检测需求预计将推动多重PCR检测市场的成长。

多重PCR检测市场的主要企业正致力于整合自动化技术，例如新一代定量PCR (qPCR) 系统，以提高核酸定量的准确性和灵活性，从而服务于先进的临床诊断和公共卫生领域。新一代qPCR系统能够实现高通量、高精度和多靶点同时检测，进而提高诊断的准确性和效率。例如，2023年11月，瑞士诊断系统解决方案供应商罗氏诊断公司 (Roche Diagnostics Corporation) 宣布推出LightCycler PRO系统。此新一代qPCR平台具有高通量、高精度和多靶点同时检测的特点，并具有更高的温度均匀性、先进的软体，以及与200多种LightMix Modular检测试剂盒和60多种CE-IVD检测试剂盒的兼容性。此次发布标誌着自动化技术在多重PCR检测市场的引进，将推动临床诊断和公共卫生事业的发展。

2023年7月，德国生物技术公司QIAGEN NV与Niba Labs达成合作。此次合作旨在透过提供尖端工具、数据分析和专业知识，推动基因组检测和个人化医疗领域的研究，从而促进生物技术和医疗保健领域的创新。 Niba Labs是一家总部位于美国的生物技术公司，专注于基因组研究、分子诊断和个人化医疗产品的开发和生产。

多重PCR检测市场包括逆转录多重PCR（RT-多重PCR）、数位多重PCR、终点多重PCR、多重连接依赖性探针扩增（MLPA）和基于探针的多重PCR的销售。该市场的价值是指“出厂价”，即产品製造商或创造者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球多重 PCR 检测：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球多重PCR检测市场：成长率分析
  • 全球多重 PCR 检测市场表现：规模与成长，2019-2024 年
  • 全球多重 PCR 检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球多重 PCR 检测：总潜在市场 (TAM)

第六章 市场细分

  • 全球多重 PCR 检测市场（依检测类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 平面测定
  • 以微珠为基础的检测
  • 全球多重 PCR 检测市场（依产品及服务划分）、实际及预测（2019-2024 年、2024-2029 年预测、2034 年预测）
  • 耗材
  • 装置
  • 软体和服务
  • 全球多重PCR检测市场：依应用、实际及预测，2019-2024年、2024-2029年、2034年
  • 疾病诊断
  • 研究与开发
  • 其他用途
  • 全球多重 PCR 检测市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 生物製药公司
  • 临床研究所
  • 学术研究机构
  • 诊断中心
  • 其他最终用户
  • 全球多重 PCR 检测市场：依平面检测类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 基于微阵列的侦测
  • DNA晶片检测
  • 全球多重 PCR 检测市场：以微珠为基础的检测方法细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • Luminex Xmap 检测
  • Magpix 检测
  • 基于流式细胞技术的珠子分析

第七章 区域和国家分析

  • 全球多重 PCR 检测市场：区域分析、预测与成长（2019-2024 年、2024-2029 年及 2034 年）
  • 全球多重 PCR 检测市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 多重 PCR 检测市场：竞争格局
  • 多重 PCR 检测市场：公司简介
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Siemens Healthineers
  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Illumina Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Tecan Group Ltd.
  • DiaSorin SpA
  • Bio-Techne Corporation
  • Promega Corporation
  • Randox Laboratories Ltd.
  • BioFire Diagnostics Inc.
  • Seegene Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年多重PCR检测市场：提供新机会的国家
  • 2029年多重PCR检测市场：细分领域带来新机会
  • 2029年多重PCR检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30750u

Multiplex PCR assays are advanced polymerase chain reaction techniques designed to simultaneously amplify and detect multiple DNA or RNA targets within a single reaction. This approach significantly enhances efficiency by enabling the analysis of various genetic markers or pathogens concurrently, offering comprehensive and cost-effective results.

The primary types of multiplex PCR assays include planar assays and bead-based assays. Planar assays are conducted on flat surfaces or platforms, such as microplates or slides, where arrays of probes are affixed to detect multiple targets in a single sample, facilitating efficient and high-throughput analysis. The product and service offerings encompass consumables, instruments, software, and services applicable to disease diagnosis, research and development, among other areas. End users of these technologies include biopharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The multiplex PCR assays market research report is one of a series of new reports from the business research company that provides multiplex PCR assays market statistics, including multiplex PCR assays industry global market size, regional shares, competitors with an multiplex PCR assays market share, detailed multiplex PCR assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex PCR assays industry. This multiplex PCR assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The multiplex pcr assays market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.7 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to the increased prevalence of infectious diseases, increasing government funding and support, increasing adoption in clinical diagnostics, rise in genetic testing and personalized medicine, increasing use in academic and research institutions, advancements in bioinformatics and data analysis tools, rising healthcare expenditure.

The multiplex pcr assays market size is expected to see rapid growth in the next few years. It will grow to $2.8 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to the expansion of application areas, rising demand for point-of-care diagnostics, growth in personalized medicine, an increase in research and development expenditures, rising health awareness and preventive healthcare, an increasing focus on precision medicine, and a and a rising demand for rapid and reliable diagnostic tests. Major trends in the forecast period include next-generation sequencing (NGS) integration, companion diagnostics, digital PCR technology, automation and high-throughput systems, point-of-care and portable devices, customization and multiplexing capabilities, artificial intelligence and machine learning, enhanced data management, and cloud solutions.

The forecast of 13.3% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on specialized polymerase enzymes from Finland, increasing expenses for comprehensive diagnostic panels and potentially limiting the availability of multi-pathogen detection tests.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing demand for diagnostic testing is projected to drive the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests used to determine the presence or absence of diseases or conditions in patients. The increasing prevalence of chronic illnesses, such as cancer and diabetes, necessitates early and precise diagnosis for effective management. Furthermore, the emphasis on preventive healthcare promotes routine testing to identify potential health issues early. Multiplex PCR assays enable the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS) reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% rise in tests conducted in May 2024 compared to the previous year. Additionally, 2.4 million diagnostic tests were performed in May 2024. This rising demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market.

Key players in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to enhance precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems provide high-throughput, accurate, and simultaneous detection of multiple targets, thus improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Swiss-based diagnostic system solutions provider, introduced the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets, featuring improved temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays. This launch exemplifies the incorporation of automation in the multiplex PCR assays market, advancing clinical diagnostics and public health.

In July 2023, QIAGEN N.V., a Germany-based biotechnology company, partnered with Niba Labs. This partnership aims to advance research in genomic testing and personalized medicine by providing cutting-edge tools, data analysis, and expertise to foster innovation in biotechnology and healthcare. Niba Labs, a US-based biotechnology company, specializes in developing and manufacturing products for genomic research, molecular diagnostics, and personalized medicine.

Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, Quanterix Corporation, NanoString Technologies, Standard BioTools Inc, Enzo Biochem Inc, SeraCare Life Sciences Inc, Agena Bioscience, Fluidigm Corporation

North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex pcr assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multiplex pcr assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiplex PCR Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiplex pcr assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiplex pcr assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The multiplex pcr assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Assay Type: Planar Assay; Bead Based Assay
  • 2) By Product And Services: Consumables; Instruments; Software And Services
  • 3) By Application: Disease Diagnosis; Research And Development; Other Applications
  • 4) By End User: Biopharmaceutical Companies; Clinical Research Organizations; Academic Research Institutes; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Planar Assay: Microarray-Based Assays; Dna Chip-Based Assays
  • 2) By Bead Based Assay: Luminex Xmap Assays; Magpix Assays; Flow Cytometry-Based Bead Assays
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc; Abbott Laboratories; Danaher Corporation; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company; Agilent Technologies Inc; PerkinElmer Inc; Illumina Inc; Sysmex Corporation; Bio-Rad Laboratories Inc; QIAGEN NV; Tecan Group Ltd; DiaSorin SpA; Bio-Techne Corporation; Promega Corporation; Randox Laboratories Ltd; BioFire Diagnostics Inc; Seegene Inc; Quanterix Corporation; NanoString Technologies; Standard BioTools Inc; Enzo Biochem Inc; SeraCare Life Sciences Inc; Agena Bioscience; Fluidigm Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Multiplex PCR Assays Market Characteristics

3. Multiplex PCR Assays Market Trends And Strategies

4. Multiplex PCR Assays Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Multiplex PCR Assays Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Multiplex PCR Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Multiplex PCR Assays Market Growth Rate Analysis
  • 5.4. Global Multiplex PCR Assays Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Multiplex PCR Assays Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Multiplex PCR Assays Total Addressable Market (TAM)

6. Multiplex PCR Assays Market Segmentation

  • 6.1. Global Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Planar Assay
  • Bead Based Assay
  • 6.2. Global Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Instruments
  • Software And Services
  • 6.3. Global Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disease Diagnosis
  • Research And Development
  • Other Applications
  • 6.4. Global Multiplex PCR Assays Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Companies
  • Clinical Research Organizations
  • Academic Research Institutes
  • Diagnostic Centers
  • Other End Users
  • 6.5. Global Multiplex PCR Assays Market, Sub-Segmentation Of Planar Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microarray-Based Assays
  • Dna Chip-Based Assays
  • 6.6. Global Multiplex PCR Assays Market, Sub-Segmentation Of Bead Based Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Luminex Xmap Assays
  • Magpix Assays
  • Flow Cytometry-Based Bead Assays

7. Multiplex PCR Assays Market Regional And Country Analysis

  • 7.1. Global Multiplex PCR Assays Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Multiplex PCR Assays Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Multiplex PCR Assays Market

  • 8.1. Asia-Pacific Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Multiplex PCR Assays Market

  • 9.1. China Multiplex PCR Assays Market Overview
  • 9.2. China Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Multiplex PCR Assays Market

  • 10.1. India Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Multiplex PCR Assays Market

  • 11.1. Japan Multiplex PCR Assays Market Overview
  • 11.2. Japan Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Multiplex PCR Assays Market

  • 12.1. Australia Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Multiplex PCR Assays Market

  • 13.1. Indonesia Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Multiplex PCR Assays Market

  • 14.1. South Korea Multiplex PCR Assays Market Overview
  • 14.2. South Korea Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Multiplex PCR Assays Market

  • 15.1. Western Europe Multiplex PCR Assays Market Overview
  • 15.2. Western Europe Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Multiplex PCR Assays Market

  • 16.1. UK Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Multiplex PCR Assays Market

  • 17.1. Germany Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Multiplex PCR Assays Market

  • 18.1. France Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Multiplex PCR Assays Market

  • 19.1. Italy Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Multiplex PCR Assays Market

  • 20.1. Spain Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Multiplex PCR Assays Market

  • 21.1. Eastern Europe Multiplex PCR Assays Market Overview
  • 21.2. Eastern Europe Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Multiplex PCR Assays Market

  • 22.1. Russia Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Multiplex PCR Assays Market

  • 23.1. North America Multiplex PCR Assays Market Overview
  • 23.2. North America Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Multiplex PCR Assays Market

  • 24.1. USA Multiplex PCR Assays Market Overview
  • 24.2. USA Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Multiplex PCR Assays Market

  • 25.1. Canada Multiplex PCR Assays Market Overview
  • 25.2. Canada Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Multiplex PCR Assays Market

  • 26.1. South America Multiplex PCR Assays Market Overview
  • 26.2. South America Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Multiplex PCR Assays Market

  • 27.1. Brazil Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Multiplex PCR Assays Market

  • 28.1. Middle East Multiplex PCR Assays Market Overview
  • 28.2. Middle East Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Multiplex PCR Assays Market

  • 29.1. Africa Multiplex PCR Assays Market Overview
  • 29.2. Africa Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Multiplex PCR Assays Market Competitive Landscape And Company Profiles

  • 30.1. Multiplex PCR Assays Market Competitive Landscape
  • 30.2. Multiplex PCR Assays Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Multiplex PCR Assays Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers
  • 31.2. Becton Dickinson and Company
  • 31.3. Agilent Technologies Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. Illumina Inc.
  • 31.6. Sysmex Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. QIAGEN NV
  • 31.9. Tecan Group Ltd.
  • 31.10. DiaSorin SpA
  • 31.11. Bio-Techne Corporation
  • 31.12. Promega Corporation
  • 31.13. Randox Laboratories Ltd.
  • 31.14. BioFire Diagnostics Inc.
  • 31.15. Seegene Inc.

32. Global Multiplex PCR Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Multiplex PCR Assays Market

34. Recent Developments In The Multiplex PCR Assays Market

35. Multiplex PCR Assays Market High Potential Countries, Segments and Strategies

  • 35.1 Multiplex PCR Assays Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Multiplex PCR Assays Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Multiplex PCR Assays Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer